These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7841036)

  • 1. Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
    Trentin L; Zambello R; Bulian P; Cerutti A; Enthammer C; Cassatella M; Nitti D; Lise M; Agostini C; Semenzato G
    Br J Cancer; 1995 Feb; 71(2):240-5. PubMed ID: 7841036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
    Trentin L; Zambello R; Bulian P; Cerutti A; Milani A; Pirone E; Nitti D; Agostini C; Semenzato G
    Br J Cancer; 1994 Jun; 69(6):1046-51. PubMed ID: 8198969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma].
    Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident research award: tumor necrosis factor alpha selectively enhances growth and cytotoxic activity of tumor infiltrating lymphocytes from human colorectal cancer.
    Stolfi VM; Milsom JW; Finke JH; Fazio VW; Fiocchi C
    J Surg Res; 1992 Jan; 52(1):39-45. PubMed ID: 1548866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
    Maeurer MJ; Walter W; Martin D; Zitvogel L; Elder E; Storkus W; Lotze MT
    Scand J Immunol; 1997 Feb; 45(2):182-92. PubMed ID: 9042431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
    Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Immunol Immunother; 1991; 32(5):280-8. PubMed ID: 1847844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.
    Steger GG; Kaboo R; deKernion JB; Figlin R; Belldegrun A
    Br J Cancer; 1995 Jul; 72(1):101-7. PubMed ID: 7599037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.
    Barth RJ; Camp BJ; Martuscello TA; Dain BJ; Memoli VA
    Cancer; 1996 Sep; 78(6):1168-78. PubMed ID: 8826937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.
    De Paola F; Ridolfi R; Riccobon A; Flamini E; Barzanti F; Granato AM; Mordenti GL; Medri L; Vitali P; Amadori D
    Br J Cancer; 2003 Jan; 88(2):320-6. PubMed ID: 12610520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.
    Donia M; Junker N; Ellebaek E; Andersen MH; Straten PT; Svane IM
    Scand J Immunol; 2012 Feb; 75(2):157-67. PubMed ID: 21955245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor-alpha and its specific 55-Kd and 75-Kd receptors in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Bulian P; Cassatella M; Raimondi R; Chisesi T; Agostini C; Semenzato G
    Blood; 1992 Oct; 80(8):2030-7. PubMed ID: 1327287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.
    Tamada K; Harada M; Ito O; Takenoyama M; Mori T; Matsuzaki G; Nomoto K
    Immunology; 1996 Dec; 89(4):627-35. PubMed ID: 9014832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3'-truncated interleukin-2 gene.
    Yamaue H; Kashmiri SV; De Filippi R; Nieroda C; Yannelli JR; Tsang KY; Schlom J
    J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):262-74. PubMed ID: 7881635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4.
    Lindgren CG; Thompson JA; Higuchi CM; Fefer A
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):322-8. PubMed ID: 8280715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF.
    Wadhwa M; Dilger P; Meager A; Walker B; Gaines-Das R; Thorpe R
    Cytokine; 1996 Dec; 8(12):900-9. PubMed ID: 9050748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Identification of the Tumor-Specific Reactive TIL Repertoire
    Draghi A; Chamberlain CA; Khan S; Papp K; Lauss M; Soraggi S; Radic HD; Presti M; Harbst K; Gokuldass A; Kverneland A; Nielsen M; Westergaard MCW; Andersen MH; Csabai I; Jönsson G; Szallasi Z; Svane IM; Donia M
    Front Immunol; 2021; 12():705422. PubMed ID: 34707600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
    Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ
    J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.